Capricor Therapeutics Inc.

In News

Capricor Therapeutics (NASDAQ: CAPR) signs 171,000 sq ft San Diego HQ lease - Stock Titan

Stock Titan - Jul 14, 2026

Capricor Therapeutics (NASDAQ:CAPR) Shares Cross Below 200 Day Moving Average - Time to Sell? - MarketBeat

MarketBeat - Jul 14, 2026

News | Capricor signs San Diego’s largest biotech lease of the year - CoStar

CoStar - Jul 16, 2026

Moderna, Takeda and Capricor on the verge of notching big drug approvals - Pharma Voice

Pharma Voice - Jul 13, 2026

CAPR Stock Gains Steam: Former Capricor Exec Could Become FDA’s Top Gene Therapy Regulator Ahead Of High-Stakes DMD Decision - Stocktwits

Stocktwits - Jul 14, 2026

Deramiocel Outlook Strengthens Capricor Therapeutics, Inc. (CAPR) as a Small-Cap Stock to Buy - Yahoo Finance

Yahoo Finance - Jun 05, 2026

Capricor to Present Positive Five-Year HOPE-2 OLE Data and - GlobeNewswire

GlobeNewswire - Jun 26, 2026

FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection - Fierce Biotech

Fierce Biotech - Mar 10, 2026

[8-K] CAPRICOR THERAPEUTICS, INC. Reports Material Event - Stock Titan

Stock Titan - Jun 26, 2026

CAPR Stock Draws Investor Attention After AAN Presentation For DMD Therapy - Stocktwits

Stocktwits - Jul 16, 2026

Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Creek Drive Management Group LLC Buys Shares of 36,000 Capricor Therapeutics, Inc. $CAPR - MarketBeat

MarketBeat - Jun 21, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment